ESPR

#2333
Esperion Therapeutics, Inc.
3.35
+1.82%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
3.35
3.35
Годовой диапазон
0.69
4.18
Дневное изменение
+1.82%
Месячное изменение
-2.05%
6-месячное изменение
+52.97%
Годовое изменение
+98.22%
Предыдущее закрытие
3.29
Open
3.35
Bid
Ask
Low
3.35
High
3.35
Объем
69
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
  • Market Capitalization 663.81 M
  • Employee 304
  • Founded N/A
  • CEO Sheldon Koenig
  • Website www.esperion.com
  • Headquarter Delaware, United States
  • FIGI BBG004KB3S72
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.65
Price to sales ratio
1.7
Dividends per share
—
Dividend yield %
—

Esperion Therapeutics Inc

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

Новости